Synopsis An Implantable Cardiac Resynchronization Therapy Defibrillator (CRT-D) is an implantable medical device that is both a cardiac resynchronization pacemaker (CRT-P) and an implantable cardioverter-defibrillator (ICD) ) dual function. It can not on.....
SynopsisCoagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels. The global Clotting Factor market size is expect.....
SynopsisRanolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that was first approved in 2006. The global Ranolazine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR .....
SynopsisChromatography detector is a device used in segregating a mixture into its individual constituents. The global Chromatography detector market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during.....
SynopsisThe global Hip Reconstruction Devices market was valued at US$ 3359 million in 2020 and is expected to reach US$ 4178 million by the end of 2027, growing at a CAGR of 2.7% during 2021-2027. This report focuses on Hip Reconstruction Devices volume and val.....
SynopsisThe Prefilled Formalin Vials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players.....
SynopsisThe Arthroscopy RF System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v.....
SynopsisElectroosmosis Pump is used for generating flow or pressure by use of an electric field. Highlights The global Electroosmosis Pumps market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 a.....
SynopsisKEYTRUDA® (pembrolizumab) works as an immunotherapy to help fight certain cancers. The global Keytruda market was valued at US$ 20940 million in 2023 and is anticipated to reach US$ 46510 million by 2030, witnessing a CAGR of 10.5% during the forecast pe.....
SynopsisThe global B-Cell Maturation Antigen (BCMA) Targeted Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475.....
